Jump to content

Analgecine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Created page with ''''Analgecine''' (brand name '''AGC''') is an analgesic extract that is approved for the treatment of back pain and neuralgia in China.<ref n...'
 
discontinued
 
(7 intermediate revisions by 4 users not shown)
Line 1: Line 1:
'''Analgecine''' (brand name '''AGC''') is an [[analgesic]] [[extract]] that is approved for the treatment of [[back pain]] and [[neuralgia]] in [[China]].<ref name="AdisInsight">http://adisinsight.springer.com/drugs/800040908</ref><ref name="DongTu2016">{{cite journal|last1=Dong|first1=Jian|last2=Tu|first2=Hung-Ping|last3=Ding|first3=Wen-Yuan|last4=Ding|first4=Yue|last5=Li|first5=Jin|last6=Zhang|first6=Xue-Li|last7=Fan|first7=Cun-Yi|last8=Dong|first8=Hai-Long|last9=Wu|first9=Yi-Chia|last10=Wang|first10=Sebrina Su-Jung|last11=Lin|first11=Chen-Lung Steve|title=Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect – A randomized multi-center double-blind placebo-controlled phase 3 clinical trial|journal=Contemporary Clinical Trials Communications|volume=2|year=2016|pages=16–24|issn=24518654|doi=10.1016/j.conctc.2015.11.002}}</ref>
'''Analgecine''' (brand name '''AGC''') is discontinued<ref name="AdisInsight">{{cite web | last=Name | first=Drug | title=Analgecine - Vanway Pharmaceutical | publisher=AdisInsight | date=2 October 2021 | url=https://adisinsight.springer.com/drugs/800040908|quote=29 Sep 2021 Discontinued - Phase-III for Neuropathic pain in China (Infusion)}}</ref> [[extracts]] of ''[[Vaccinia]]''-[[Inoculation|inoculated]] rabbit skin used as an [[analgesic]], that had been approved for the treatment of [[back pain]] and [[neuralgia]] in China.<ref name="AdisInsight"/><ref name="DongTu2016">{{cite journal|last1=Dong|first1=Jian|last2=Tu|first2=Hung-Ping|last3=Ding|first3=Wen-Yuan|last4=Ding|first4=Yue|last5=Li|first5=Jin|last6=Zhang|first6=Xue-Li|last7=Fan|first7=Cun-Yi|last8=Dong|first8=Hai-Long|last9=Wu|first9=Yi-Chia|last10=Wang|first10=Sebrina Su-Jung|last11=Lin|first11=Chen-Lung Steve|title=Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect – A randomized multi-center double-blind placebo-controlled phase 3 clinical trial|journal=Contemporary Clinical Trials Communications|volume=2|year=2016|pages=16–24|issn=2451-8654|doi=10.1016/j.conctc.2015.11.002|doi-access=free|pmid=29736443|pmc=5935851}}</ref>


==References==
==References==
Line 5: Line 5:


==External links==
==External links==
* {{cite web | publisher=Vanway | title=Analgecine | date=2014 | url=http://www.vanworld-pharmaceutical.com/analgecine/ | archive-url=https://web.archive.org/web/20210417091638/http://www.vanworld-pharmaceutical.com/analgecine/ | archive-date=17 April 2021 | url-status=dead}}
* [http://adisinsight.springer.com/drugs/800040908 Analgecine - AdisInsight]
* [http://www.vanworld-pharmaceutical.com/analgecine/ Analgecine - Vanway]



{{Analgesics}}
{{Analgesics}}

Latest revision as of 15:44, 9 July 2023

Analgecine (brand name AGC) is discontinued[1] extracts of Vaccinia-inoculated rabbit skin used as an analgesic, that had been approved for the treatment of back pain and neuralgia in China.[1][2]

References

[edit]
  1. ^ a b Name, Drug (2 October 2021). "Analgecine - Vanway Pharmaceutical". AdisInsight. 29 Sep 2021 Discontinued - Phase-III for Neuropathic pain in China (Infusion)
  2. ^ Dong, Jian; Tu, Hung-Ping; Ding, Wen-Yuan; Ding, Yue; Li, Jin; Zhang, Xue-Li; Fan, Cun-Yi; Dong, Hai-Long; Wu, Yi-Chia; Wang, Sebrina Su-Jung; Lin, Chen-Lung Steve (2016). "Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect – A randomized multi-center double-blind placebo-controlled phase 3 clinical trial". Contemporary Clinical Trials Communications. 2: 16–24. doi:10.1016/j.conctc.2015.11.002. ISSN 2451-8654. PMC 5935851. PMID 29736443.
[edit]